Lessons from the COMPASS-3 Study

Por Shah, Trushil, Chin, Kelly M
Publicado no Pulm Circ (2018)

Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapy

Por Hardin, Elizabeth Ashley, Chin, Kelly M
Publicado no Drug Des Devel Ther (2016)

Pulmonary Arterial Hypertension—Symptoms and Impact Questionnaire: feasibility of utilizing one-day versus seven-day symptom reporting

Por Frantz, Robert P., Chin, Kelly M., Zhao, Carol, Flynn, Megan, Badesch, David
Publicado no Pulm Circ (2020)

Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis

Por Cronkhite, Jennifer T., Xing, Chao, Raghu, Ganesh, Chin, Kelly M., Torres, Fernando, Rosenblatt, Randall L., Garcia, Christine Kim
Publicado em 2008

Left atrial structure and function and clinical outcomes in the general population

Por Gupta, Sachin, Matulevicius, Susan A., Ayers, Colby R., Berry, Jarett D., Patel, Parag C., Markham, David W., Levine, Benjamin D., Chin, Kelly M., de Lemos, James A., Peshock, Ronald M., Drazner, Mark H.
Publicado em 2013

Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension: Insights From the Phase III GRIPHON Study

Por Chin, Kelly M., Rubin, Lewis J., Channick, Richard, Di Scala, Lilla, Gaine, Sean, Galiè, Nazzareno, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M., Lang, Irene M., McLaughlin, Vallerie V., Preiss, Ralph, Simonneau, Gérald, Sitbon, Olivier, Tapson, Victor F.
Publicado no Circulation (2019)

Selexipag treatment for pulmonary arterial hypertension associated with congenital heart disease after defect correction: insights from the randomised controlled GRIPHON study

Por Beghetti, Maurice, Channick, Richard N., Chin, Kelly M., Di Scala, Lilla, Gaine, Sean, Ghofrani, Hossein‐Ardeschir, Hoeper, Marius M., Lang, Irene M., McLaughlin, Vallerie V., Preiss, Ralph, Rubin, Lewis J., Simonneau, Gérald, Sitbon, Olivier, Tapson, Victor F., Galiè, Nazzareno
Publicado no Eur J Heart Fail (2019)